- IBDEI1EP ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,22748,2)
- ;;=^5001059
- ;;^UTILITY(U,$J,358.3,22749,0)
- ;;=C44.622^^76^978^15
- ;;^UTILITY(U,$J,358.3,22749,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22749,1,3,0)
- ;;=3^SCC Skin Right Upper Limb
- ;;^UTILITY(U,$J,358.3,22749,1,4,0)
- ;;=4^C44.622
- ;;^UTILITY(U,$J,358.3,22749,2)
- ;;=^5001070
- ;;^UTILITY(U,$J,358.3,22750,0)
- ;;=C44.629^^76^978^6
- ;;^UTILITY(U,$J,358.3,22750,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22750,1,3,0)
- ;;=3^SCC Skin Left Upper Limb
- ;;^UTILITY(U,$J,358.3,22750,1,4,0)
- ;;=4^C44.629
- ;;^UTILITY(U,$J,358.3,22750,2)
- ;;=^5001071
- ;;^UTILITY(U,$J,358.3,22751,0)
- ;;=C44.722^^76^978^14
- ;;^UTILITY(U,$J,358.3,22751,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22751,1,3,0)
- ;;=3^SCC Skin Right Lower Limb
- ;;^UTILITY(U,$J,358.3,22751,1,4,0)
- ;;=4^C44.722
- ;;^UTILITY(U,$J,358.3,22751,2)
- ;;=^5001082
- ;;^UTILITY(U,$J,358.3,22752,0)
- ;;=C44.729^^76^978^5
- ;;^UTILITY(U,$J,358.3,22752,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22752,1,3,0)
- ;;=3^SCC Skin Left Lower Limb
- ;;^UTILITY(U,$J,358.3,22752,1,4,0)
- ;;=4^C44.729
- ;;^UTILITY(U,$J,358.3,22752,2)
- ;;=^5001083
- ;;^UTILITY(U,$J,358.3,22753,0)
- ;;=C44.82^^76^978^10
- ;;^UTILITY(U,$J,358.3,22753,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22753,1,3,0)
- ;;=3^SCC Skin Overlapping Sites
- ;;^UTILITY(U,$J,358.3,22753,1,4,0)
- ;;=4^C44.82
- ;;^UTILITY(U,$J,358.3,22753,2)
- ;;=^5001089
- ;;^UTILITY(U,$J,358.3,22754,0)
- ;;=L57.8^^76^978^36
- ;;^UTILITY(U,$J,358.3,22754,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22754,1,3,0)
- ;;=3^Skin Changes d/t Chr Exposure to Nonionizing Radiation
- ;;^UTILITY(U,$J,358.3,22754,1,4,0)
- ;;=4^L57.8
- ;;^UTILITY(U,$J,358.3,22754,2)
- ;;=^5009226
- ;;^UTILITY(U,$J,358.3,22755,0)
- ;;=L27.0^^76^978^37
- ;;^UTILITY(U,$J,358.3,22755,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22755,1,3,0)
- ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
- ;;^UTILITY(U,$J,358.3,22755,1,4,0)
- ;;=4^L27.0
- ;;^UTILITY(U,$J,358.3,22755,2)
- ;;=^5009144
- ;;^UTILITY(U,$J,358.3,22756,0)
- ;;=L27.1^^76^978^38
- ;;^UTILITY(U,$J,358.3,22756,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22756,1,3,0)
- ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
- ;;^UTILITY(U,$J,358.3,22756,1,4,0)
- ;;=4^L27.1
- ;;^UTILITY(U,$J,358.3,22756,2)
- ;;=^5009145
- ;;^UTILITY(U,$J,358.3,22757,0)
- ;;=L51.1^^76^978^44
- ;;^UTILITY(U,$J,358.3,22757,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22757,1,3,0)
- ;;=3^Stevens-Johnson Syndrome
- ;;^UTILITY(U,$J,358.3,22757,1,4,0)
- ;;=4^L51.1
- ;;^UTILITY(U,$J,358.3,22757,2)
- ;;=^336636
- ;;^UTILITY(U,$J,358.3,22758,0)
- ;;=L51.3^^76^978^45
- ;;^UTILITY(U,$J,358.3,22758,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22758,1,3,0)
- ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
- ;;^UTILITY(U,$J,358.3,22758,1,4,0)
- ;;=4^L51.3
- ;;^UTILITY(U,$J,358.3,22758,2)
- ;;=^336637
- ;;^UTILITY(U,$J,358.3,22759,0)
- ;;=Z12.83^^76^978^21
- ;;^UTILITY(U,$J,358.3,22759,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22759,1,3,0)
- ;;=3^Screening for Malig Neop of Skin
- ;;^UTILITY(U,$J,358.3,22759,1,4,0)
- ;;=4^Z12.83
- ;;^UTILITY(U,$J,358.3,22759,2)
- ;;=^5062696
- ;;^UTILITY(U,$J,358.3,22760,0)
- ;;=Z48.817^^76^978^48
- ;;^UTILITY(U,$J,358.3,22760,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,22760,1,3,0)
- ;;=3^Surgical Aftercare Following Skin Surgery
- ;;^UTILITY(U,$J,358.3,22760,1,4,0)
- ;;=4^Z48.817
- ;;^UTILITY(U,$J,358.3,22760,2)
- ;;=^5063054
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1EP 3787 printed Jan 18, 2025@03:08:28 Page 2
- IBDEI1EP ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,22748,2)
- +2 ;;=^5001059
- +3 ;;^UTILITY(U,$J,358.3,22749,0)
- +4 ;;=C44.622^^76^978^15
- +5 ;;^UTILITY(U,$J,358.3,22749,1,0)
- +6 ;;=^358.31IA^4^2
- +7 ;;^UTILITY(U,$J,358.3,22749,1,3,0)
- +8 ;;=3^SCC Skin Right Upper Limb
- +9 ;;^UTILITY(U,$J,358.3,22749,1,4,0)
- +10 ;;=4^C44.622
- +11 ;;^UTILITY(U,$J,358.3,22749,2)
- +12 ;;=^5001070
- +13 ;;^UTILITY(U,$J,358.3,22750,0)
- +14 ;;=C44.629^^76^978^6
- +15 ;;^UTILITY(U,$J,358.3,22750,1,0)
- +16 ;;=^358.31IA^4^2
- +17 ;;^UTILITY(U,$J,358.3,22750,1,3,0)
- +18 ;;=3^SCC Skin Left Upper Limb
- +19 ;;^UTILITY(U,$J,358.3,22750,1,4,0)
- +20 ;;=4^C44.629
- +21 ;;^UTILITY(U,$J,358.3,22750,2)
- +22 ;;=^5001071
- +23 ;;^UTILITY(U,$J,358.3,22751,0)
- +24 ;;=C44.722^^76^978^14
- +25 ;;^UTILITY(U,$J,358.3,22751,1,0)
- +26 ;;=^358.31IA^4^2
- +27 ;;^UTILITY(U,$J,358.3,22751,1,3,0)
- +28 ;;=3^SCC Skin Right Lower Limb
- +29 ;;^UTILITY(U,$J,358.3,22751,1,4,0)
- +30 ;;=4^C44.722
- +31 ;;^UTILITY(U,$J,358.3,22751,2)
- +32 ;;=^5001082
- +33 ;;^UTILITY(U,$J,358.3,22752,0)
- +34 ;;=C44.729^^76^978^5
- +35 ;;^UTILITY(U,$J,358.3,22752,1,0)
- +36 ;;=^358.31IA^4^2
- +37 ;;^UTILITY(U,$J,358.3,22752,1,3,0)
- +38 ;;=3^SCC Skin Left Lower Limb
- +39 ;;^UTILITY(U,$J,358.3,22752,1,4,0)
- +40 ;;=4^C44.729
- +41 ;;^UTILITY(U,$J,358.3,22752,2)
- +42 ;;=^5001083
- +43 ;;^UTILITY(U,$J,358.3,22753,0)
- +44 ;;=C44.82^^76^978^10
- +45 ;;^UTILITY(U,$J,358.3,22753,1,0)
- +46 ;;=^358.31IA^4^2
- +47 ;;^UTILITY(U,$J,358.3,22753,1,3,0)
- +48 ;;=3^SCC Skin Overlapping Sites
- +49 ;;^UTILITY(U,$J,358.3,22753,1,4,0)
- +50 ;;=4^C44.82
- +51 ;;^UTILITY(U,$J,358.3,22753,2)
- +52 ;;=^5001089
- +53 ;;^UTILITY(U,$J,358.3,22754,0)
- +54 ;;=L57.8^^76^978^36
- +55 ;;^UTILITY(U,$J,358.3,22754,1,0)
- +56 ;;=^358.31IA^4^2
- +57 ;;^UTILITY(U,$J,358.3,22754,1,3,0)
- +58 ;;=3^Skin Changes d/t Chr Exposure to Nonionizing Radiation
- +59 ;;^UTILITY(U,$J,358.3,22754,1,4,0)
- +60 ;;=4^L57.8
- +61 ;;^UTILITY(U,$J,358.3,22754,2)
- +62 ;;=^5009226
- +63 ;;^UTILITY(U,$J,358.3,22755,0)
- +64 ;;=L27.0^^76^978^37
- +65 ;;^UTILITY(U,$J,358.3,22755,1,0)
- +66 ;;=^358.31IA^4^2
- +67 ;;^UTILITY(U,$J,358.3,22755,1,3,0)
- +68 ;;=3^Skin Eruption,Generalized d/t Drugs/Meds Taken Internally
- +69 ;;^UTILITY(U,$J,358.3,22755,1,4,0)
- +70 ;;=4^L27.0
- +71 ;;^UTILITY(U,$J,358.3,22755,2)
- +72 ;;=^5009144
- +73 ;;^UTILITY(U,$J,358.3,22756,0)
- +74 ;;=L27.1^^76^978^38
- +75 ;;^UTILITY(U,$J,358.3,22756,1,0)
- +76 ;;=^358.31IA^4^2
- +77 ;;^UTILITY(U,$J,358.3,22756,1,3,0)
- +78 ;;=3^Skin Eruption,Localized d/t Drugs/Meds Taken Internally
- +79 ;;^UTILITY(U,$J,358.3,22756,1,4,0)
- +80 ;;=4^L27.1
- +81 ;;^UTILITY(U,$J,358.3,22756,2)
- +82 ;;=^5009145
- +83 ;;^UTILITY(U,$J,358.3,22757,0)
- +84 ;;=L51.1^^76^978^44
- +85 ;;^UTILITY(U,$J,358.3,22757,1,0)
- +86 ;;=^358.31IA^4^2
- +87 ;;^UTILITY(U,$J,358.3,22757,1,3,0)
- +88 ;;=3^Stevens-Johnson Syndrome
- +89 ;;^UTILITY(U,$J,358.3,22757,1,4,0)
- +90 ;;=4^L51.1
- +91 ;;^UTILITY(U,$J,358.3,22757,2)
- +92 ;;=^336636
- +93 ;;^UTILITY(U,$J,358.3,22758,0)
- +94 ;;=L51.3^^76^978^45
- +95 ;;^UTILITY(U,$J,358.3,22758,1,0)
- +96 ;;=^358.31IA^4^2
- +97 ;;^UTILITY(U,$J,358.3,22758,1,3,0)
- +98 ;;=3^Stevens-Johnson Syndrome-Toxic Epdrml Necrolysis Overlap Syndrome
- +99 ;;^UTILITY(U,$J,358.3,22758,1,4,0)
- +100 ;;=4^L51.3
- +101 ;;^UTILITY(U,$J,358.3,22758,2)
- +102 ;;=^336637
- +103 ;;^UTILITY(U,$J,358.3,22759,0)
- +104 ;;=Z12.83^^76^978^21
- +105 ;;^UTILITY(U,$J,358.3,22759,1,0)
- +106 ;;=^358.31IA^4^2
- +107 ;;^UTILITY(U,$J,358.3,22759,1,3,0)
- +108 ;;=3^Screening for Malig Neop of Skin
- +109 ;;^UTILITY(U,$J,358.3,22759,1,4,0)
- +110 ;;=4^Z12.83
- +111 ;;^UTILITY(U,$J,358.3,22759,2)
- +112 ;;=^5062696
- +113 ;;^UTILITY(U,$J,358.3,22760,0)
- +114 ;;=Z48.817^^76^978^48
- +115 ;;^UTILITY(U,$J,358.3,22760,1,0)
- +116 ;;=^358.31IA^4^2
- +117 ;;^UTILITY(U,$J,358.3,22760,1,3,0)
- +118 ;;=3^Surgical Aftercare Following Skin Surgery
- +119 ;;^UTILITY(U,$J,358.3,22760,1,4,0)
- +120 ;;=4^Z48.817
- +121 ;;^UTILITY(U,$J,358.3,22760,2)
- +122 ;;=^5063054